Crestline Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,276
| Closed | -$1.27M | – | 765 |
|
|
2024
Q3 | $1.27M | Buy |
+19,276
| New | +$1.27M | 0.07% | 236 |
|
|
2022
Q1 | – | Sell |
-16,656
| Closed | -$2.16M | – | 273 |
|
|
2021
Q4 | $2.16M | Sell |
16,656
-8,427
| -34% | -$1.09M | 0.16% | 112 |
|
|
2021
Q3 | $2.84M | Buy |
+25,083
| New | +$2.84M | 0.27% | 83 |
|
|
2017
Q1 | – | Sell |
-58,341
| Closed | -$1.82M | – | 121 |
|
|
2016
Q4 | $1.82M | Buy |
+58,341
| New | +$1.82M | 0.45% | 10 |
|